Efficacy of ferric carboxymaltose on haemoglobin response among older patients with gastrointestinal bleeding: a randomised clinical trial

Abstract Background Acute gastrointestinal bleeding (AGIB) is common in older patients but the use of iron in this context remains understudied. Aims This study aimed to evaluate prospectively the efficacy of ferric carboxymaltose to treat anaemia in older patients after AGIB. Methods This randomise...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Age and ageing 2024-05, Vol.53 (5)
Hauptverfasser:	Richard, Nicolas, Arab-Hocine, Nadia, Vannier, Margot, Leblanc-Boubchir, Rachida, Pelaquier, Agnès, Boruchowicz, Arnaud, Musikas, Marietta, Amil, Morgane, Fumery, Mathurin, Nahon, Stéphane, Arotcarena, Ramuntcho, Gelsi, Eve, Maurin, Arnaud, Hébuterne, Xavier, Savoye, Guillaume
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Age Factors Aged Aged, 80 and over Anemia Bleeding Cancer Clinical research Clinical trials Critical incidents Double-Blind Method Efficacy Female Ferric Compounds - administration & dosage Ferric Compounds - adverse effects Ferric Compounds - therapeutic use France Gastrointestinal Hemorrhage - drug therapy Hematinics - administration & dosage Hematinics - adverse effects Hematinics - therapeutic use Hemoglobin Hemoglobins - analysis Hemoglobins - metabolism Humans Injections, Intravenous Intravenous administration Iron Life Sciences Male Maltose - administration & dosage Maltose - adverse effects Maltose - analogs & derivatives Maltose - therapeutic use Patients Placebos Prospective Studies Quality of Life Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!